Literature DB >> 18586329

Non-paraneoplastic limbic encephalitis associated with anti-glutamic acid decarboxylase antibodies.

Sabrina Matà1, Gian Carlo Muscas, Ilaria Naldi, Eleonora Rosati, Sergio Paladini, Barbara Cruciatti, Francesca Bisulli, Marco Paganini, Gustavo Mazzi, Sandro Sorbi, Paolo Tinuper.   

Abstract

Limbic encephalitis (LE) is a neurological syndrome that may present in association with cancer, infection, or as an isolate clinical condition often accompanying autoimmune disorders. Here we have characterized the clinical and laboratory features of two patients presenting with subacute onset, and chronic evolution, of anterograde amnesia and drug-resistant epilepsy associated with thyroid autoimmunity and in absence of tumoral pathology despite long follow-up. Antibodies against onconeural antigens, voltage gated potassium channel and glutamate receptors, which may accompany paraneoplastic as well as non-paraneoplastic LE, were negative. However, biochemical studies showed high titers, and sustained intrathecal synthesis, of antibodies directed against neuronal glutamic acid decarboxylase (GAD). In one patient, plasma exchange determined a dramatic improvement of the neurological deficits along with the decrease of autoantibodies.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18586329     DOI: 10.1016/j.jneuroim.2008.05.015

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  23 in total

1.  Epilepsy in coeliac disease: not just a matter of calcifications.

Authors:  Laura Licchetta; Francesca Bisulli; Lidia Di Vito; Chiara La Morgia; Ilaria Naldi; Umberto Volta; Paolo Tinuper
Journal:  Neurol Sci       Date:  2011-06-01       Impact factor: 3.307

Review 2.  Autoimmune-mediated encephalitis.

Authors:  Philippe Demaerel; Wim Van Dessel; Wim Van Paesschen; Rik Vandenberghe; Koen Van Laere; Jennifer Linn
Journal:  Neuroradiology       Date:  2011-01-27       Impact factor: 2.804

Review 3.  Immune mediated diseases and immune modulation in the neurocritical care unit.

Authors:  Gloria von Geldern; Thomas McPharlin; Kyra Becker
Journal:  Neurotherapeutics       Date:  2012-01       Impact factor: 7.620

4.  Treatment of anti-glutamic acid decarboxylase antibody-associated limbic encephalitis with mycophenolate mofetil.

Authors:  Shiv Saidha; S Murphy; A Ronayne; P McCarthy; M J Hennessy; T Counihan
Journal:  J Neurol       Date:  2010-02-04       Impact factor: 4.849

Review 5.  [Antibody-associated diseases of the gray matter of the CNS: diagnosis and treatment].

Authors:  C G Bien
Journal:  Nervenarzt       Date:  2011-08       Impact factor: 1.214

Review 6.  Antibodies in epilepsy.

Authors:  Cynthia M Correll
Journal:  Curr Neurol Neurosci Rep       Date:  2013-05       Impact factor: 5.081

7.  GABA-A receptor impairment in cerebellar ataxia with anti-glutamic acid decarboxylase antibodies.

Authors:  Yasushi Hosoi; Makiko Suzuki-Sakao; Tatsuhiro Terada; Takashi Konishi; Yasuomi Ouchi; Hiroaki Miyajima; Satoshi Kono
Journal:  J Neurol       Date:  2013-10-05       Impact factor: 4.849

8.  Limbic encephalitis and related cortical syndromes.

Authors:  Ignacio Rubio-Agusti; Miguel Salavert; Luis Bataller
Journal:  Curr Treat Options Neurol       Date:  2013-04       Impact factor: 3.598

9.  Antibodies to the GABA(B) receptor in limbic encephalitis with seizures: case series and characterisation of the antigen.

Authors:  Eric Lancaster; Meizan Lai; Xiaoyu Peng; Ethan Hughes; Radu Constantinescu; Jeffrey Raizer; Daniel Friedman; Mark B Skeen; Wolfgang Grisold; Akio Kimura; Kouichi Ohta; Takahiro Iizuka; Miguel Guzman; Francesc Graus; Stephen J Moss; Rita Balice-Gordon; Josep Dalmau
Journal:  Lancet Neurol       Date:  2009-12-02       Impact factor: 44.182

Review 10.  Encephalitis and epilepsy.

Authors:  Jan Bauer; Christian G Bien
Journal:  Semin Immunopathol       Date:  2009-09-11       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.